Sequenom, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

SQNM 2.23 +0.09 (4.21%)
price chart
Sequenom, Inc. (NASDAQ:SQNM) Price Target Update
Sequenom, Inc. (NASDAQ:SQNM) shares are expected to touch $4.38 in the short term. This short term price target has been shared by 4 analysts.
Shares of Sequenom, Inc. (NASDAQ:SQNM) Sees Large Inflow of Net Money  American Trade Journal
Hot Stocks: Suncor Energy Inc. (NYSE:SU), ACADIA Pharmaceuticals Inc ...  Stock Transcript
Biotech Stocks For Your Portfolio - Progenics Pharmaceuticals, Inc. (NASDAQ ...
Sequenom, Inc. (NASDAQ:SQNM) rose 2.39% to finish last trading session at $2.14. The company, on August 25, 2015, reported that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.
Company Update (NASDAQ:SQNM): Sequenom, Inc. Enters Collaboration With UC San ...
Sequenom, Inc. (NASDAQ:SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical research collaboration with the University of ...
Sequenom Enters Collaboration With UC San Diego Moores Cancer Center With ...  PR Newswire (press release)
Zacks Short Term Rating on Sequenom, Inc. (NASDAQ:SQNM)
As many as 5 brokerage firms have rated Sequenom, Inc. (NASDAQ:SQNM) at 2.2. Research Analysts at Zacks have ranked the company at 4, suggesting the traders with a rating of sell for the short term.
Shares of Sequenom, Inc. (NASDAQ:SQNM) Sees Large Outflow of Money  News Watch International
Sequenom, Inc. (NASDAQ:SQNM) Given $2.5-$7 PT Range  Markets Daily
Sequenom, Inc. Short Interest Update
Sequenom, Inc. (NASDAQ:SQNM) has witnessed a drop of 3% or 561,537 shares in its short figure. The short interest diminution took it from 18,742,240 on July 31,2015 to 18,180,703 on August 14,2015.
Growth Stock Watch: Sequenom, Inc. (NASDAQ:SQNM)  Enterprise Leader
Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2015
"We are pleased with the improvement in our operations and cash burn," said Bill Welch, President and Chief Executive Officer of Sequenom, Inc. "As expected, we increased revenues from global patent pool licensees while we saw a decline in test volume ...
Here's Why Sequenom Inc.'s Shares Cratered Today
What: Sequenom (NASDAQ:SQNM) reported its second-quarter earnings today, triggering a 28% drop in its share price on exceptional volume.
Sequenom, Inc. (SQNM:NASDAQ) Analyst Price Target Update  Insider Trading Report
Sequenom, Inc. (NASDAQ:SQNM) Brokerage Rating Update  Investor Newswire
Sequenom, Inc. Price Target Update
Sequenom, Inc. (NASDAQ:SQNM) should head towards $4.38 per share according to 4 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $3 per share.
3 Sizzling Hot Biotech Stocks - Intrexon Corp (NYSE:XON), Sequenom, Inc ...
Sequenom, Inc. (NASDAQ:SQNM) rose 3.98% to finish last trading session at $2.09. The company, on August 25, 2015, reported that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.
Short Interest Update on Sequenom, Inc. (NASDAQ:SQNM)
Sequenom, Inc. (NASDAQ:SQNM) reported a rise of 0.7% or 122,447 shares in its short interest. The short figure came in at 16% of the total floats.
Sequenom, Inc. Announces 2015 Investor And Analyst Day  CNNMoney
Stock Update (NASDAQ:SQNM): Sequenom, Inc. Announces 2015 Investor And ...  Smarter Analyst